The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the ...

A successful M&A outcome is contingent upon a deep understanding of the regulatory and scientific fundamentals that underpin ...

Identifying the priorities that translate to strong business outcomes—and separating the top performers from the average ...

On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Proposed cuts to Medicaid will have significant impacts on the health industry. One area that will be heavily impacted by ...

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and ...

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...

The idea of creating a gray zone in the payer message is to take the onus off of having to heavily discount for equal access ...

Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement ...

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years ...

Will Pih, co-founder, Two Labs, explains how ongoing regulatory uncertainty is slowing clinical trial activity and hiring ...